Completed PHASE2 INTERVENTIONAL 1-arm NCT01111773

Study Evaluating a Heated Lidocaine and Tetracaine Topical Patch in the Treatment of Patients With Patellar Tendinopathy

An Open-label Pilot Study Evaluating Synera® in the Treatment of Patients With Patellar Tendinopathy

Sponsor: ZARS Pharma Inc.

Interventions Heated Lidocaine and Tetracaine Patch

Updated 7 times since 2017 Last updated: Mar 14, 2012 Started: Jun 30, 2010 Primary completion: Mar 31, 2011 Completion: May 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Patellar Tendinopathy and is currently completed. ZARS Pharma Inc. leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ZARS Pharma Inc.

Data source: ZARS Pharma Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Warren, United States